Brief introduction of Li Gan Pharmaceutical Co., Ltd.

Li Gan Pharmaceutical Co., Ltd., founded in 1998, is a high-tech biopharmaceutical enterprise integrating scientific research, development, production and sales. The company is in a leading position at home and abroad in the development, research and production of biosynthetic human insulin and its analogues, and is a professional company specializing in biosynthetic human insulin analogues. The company's product line is complete, and the product quality reaches the European and American pharmacopoeia standards. 20 13 September, Li Gan Pharmaceutical Insulin was exposed that the IPO was suspected of bribing nearly 300 million 20 12. 2065438+2004 10.8, a person from the economic investigation department of Hubei Province told the reporter of 2 1 Century Business Herald: "2065438+200310, 165438, the police formally arrested seven medicines from Li Gan Pharmaceutical Company in Hubei. In September of 20 13, an anonymous person broke the news that Li Gan pharmaceutical industry was involved in a commercial bribery scandal, and the total amount of bribes in 20 12 may be as high as 300 million yuan. Before the news broke, the person had reported the case to the Hubei Economic Investigation Department. The Economic Investigation Department started the investigation on August 20 13.